找到1391记录 | 不满意,请使用左下搜索矩阵
排序: 相关性 发表日期 影响因子

Medications with TNF-alpha inhibitors family are successfully applicable in rheumatology, gastroe...



The growing number of disease-modifying medications approved for multiple sclerosis (MS) treatmen...

期刊:Continuum (Minneap Minn)  影响因子:0.0  发表日期: 20130801  PMID: 23917104 


BACKGROUND: Treatment with natalizumab, a humanized monoclonal antibody against alpha4beta1 integ...

期刊:Mult Scler  影响因子:0.0  发表日期: 20131001  PMID: 23439578 


BACKGROUND: Over some 50 years, field surveys have shown that the prevalence of multiple sclerosi...



Progressive Multifocal Leucoencephalopathy (PML) is a rare and invariably fatal neurological dise...





One of the most effective multiple sclerosis (MS) treatment is natalizumab. Nevertheless, it has ...

期刊:J Neuroimmune Pharmacol  影响因子:0.0  发表日期: 20131201  PMID: 23979860 


BACKGROUND: Osteopontin (OPN) is a pleiotropic protein with important roles in inflammation and i...

期刊:Mult Scler  影响因子:0.0  发表日期: 20140401  PMID: 24005026 


    相关搜索:
    菠萝视频下载安装